Skip to content
GOOGL$281.29-1.31(-0.46%)UPDATE 2-Alphabet takes $548 million stake in partner Qualcomm in data center push7:42:43 AM ETPEP$139.16-3.61(-2.53%)If You Invested $300,000 in Coca-Cola, PepsiCo and Keurig Dr Pepper, Here's What They'd Pay7:37:28 AM ETNVDA$188.74+7.15(+3.94%)Nvidia Just Had Its Worst Day Since DeepSeek, Losing About $450 Billion7:37:04 AM ETCMCSA$24.25-0.73(-2.92%)UPDATE 1-UK broadcaster Sky received security threat, as alerts sweep Europe7:35:58 AM ETMRNA$252.92+11.72(+4.86%)Moderna Lifts Full-Year Outlook, Swings to Quarterly Profit7:34:00 AM ETPLTR$158.73+3.82(+2.47%)Prediction: $5,000 Invested in Palantir Will Be Worth This Much by 20317:33:00 AM ETBN$41.74-0.02(-0.05%)Brookfield Asset Management Fundraises $25 Billion in Quarter, Led by Infrastructure Strategies7:30:00 AM ETCMCSA$24.25-0.73(-2.92%)UK broadcaster Sky says it received security threat7:28:07 AM ETMMM$186.35-1.42(-0.76%)3M: Strong Order Momentum And Improving Execution Point To More Upside7:25:39 AM ETEQIX$1,001.00+3.65(+0.37%)Wall Street's Loudest Voices Split on Whether the AI Trade Is Finished7:22:47 AM ETTGT$155.35-2.58(-1.63%)Own Target Stock by Nov. 9 to Qualify for Its Dec. 1 Dividend. Here's How Many Shares of the Dividend King You'd Need for $2,000 in Yearly Dividends.7:22:00 AM ETKO$94.09-1.78(-1.86%)Coca-Cola Has Raised Its Dividend for 64 Straight Years. Here's What $10,000 Will Pay You in 2027.7:22:00 AM ETTSLA$349.37+6.05(+1.76%)Tesla and SpaceX Have Lost $457 Billion in Two Days7:21:49 AM ETLLY$1,353.00-14.10(-1.03%)BRIEF-Eli Lilly & Hims & Hers Health Announce Agreement To Expand Access To Zepbound & Foundayo7:20:47 AM ETMRNA$252.92+11.72(+4.86%)BRIEF-Moderna Expects Total Revenue Growth Of 15% To 25% In 20267:18:41 AM ETEGP$193.86-7.14(-3.55%)These Warehouse REITs Are Riding the E-Commerce Boom. Which Pays the Safest Dividend?7:17:09 AM ETWEST$9.54-0.82(-7.92%)What Westrock Coffee (WEST) Said on Its Q3 Earnings Call7:16:59 AM ETTSX:ENB$67.33-0.69(-1.01%)Canada's Enbridge Q3 EBITDA rises on higher gas transmission, distribution rates7:16:38 AM ETTSX:ENB$67.33-0.69(-1.01%)UPDATE 1-Enbridge's quarterly profit rises on strength in natural gas businesses7:16:06 AM ETPLTR$158.73+3.82(+2.47%)Palantir Shed Nearly 20% Over 12 Months: This Wall Street Desk Predicts 76% Gains Moving Forward7:15:57 AM ETBAM$53.90+1.44(+2.74%)Brookfield Asset Management Q3 fee-related earnings rise on Oaktree acquisition7:15:42 AM ETAAPL$340.00-4.40(-1.28%)Apple Is Virtually Insulated From Blue-Wave Pain Points7:15:30 AM ETAAPL$340.00-4.40(-1.28%)Apple Vs. Alphabet: The Midterms Just Separated Them from The Mag 7 Pack7:15:26 AM ETGOOG$280.73-1.14(-0.40%)Alphabet is The Best Positioned Hyperscaler for This Blue Wave AI-Energy Regulation Shift7:15:12 AM ET

TMCI · NASDAQ

Treace Medical Concepts, Inc.

$4.36 +0.20 (+4.81%)

Company overview

Treace Medical Concepts, Inc., an orthopedic medical device company, designs, manufactures, and markets medical devices for foot and ankle surgeons in the United States. It offers the Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with cosmetic and medical improvement. The company also provides the Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, Weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Market cap
$284M
Employees
477
Headquarters
Ponte Vedra, FL
Website
treace.com
CEO
John T. Treace
Listed
April 23, 2021
P/E
-4.49
Dividend yield
0.00%

Company financials

Revenue
$207M
Gross profit
$165M
Operating income
-$55.7M
EBITDA
-$47.1M
Net income
-$61M
EPS
-$0.97
Total assets
$184M
Total debt
$13.6M
Gross margin
79.72%
Net margin
-29.44%
Earnings yield
-22.25%

Price chart

1.642.573.514.455.39
TMCI 1D NASDAQ O4.48H4.50L3.96C4.16-0.34 (-7.56%)Vol289.35K

News

LiveHeadlines show up as soon as they are ingested, with ticker, type, source, and time.

Pro

15-min delayYour Free plan is delayed 15 minutes. Pro opens the live desk.

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Since 2020This range is older than the last year on your plan. Pro opens articles since 2020.

Source
Date
Type
View
Ticker Type Headline Source Published
TMCITreace Medical Concepts, Inc. Stock news Treace Medical Q3 revenue falls but slightly beats expectations Reuters
TMCITreace Medical Concepts, Inc. Stock news BRIEF-Treace Medical Q3 EPS USD -0.19 Reuters
TMCITreace Medical Concepts, Inc. Press release Treace Medical Concepts Reports Third Quarter 2026 Financial Results GlobeNewswire
TMCITreace Medical Concepts, Inc. Press release Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System GlobeNewswire
TMCITreace Medical Concepts, Inc. Press release Treace to Present at the Stifel 2026 Healthcare Conference GlobeNewswire
TMCITreace Medical Concepts, Inc. Press release Treace to Report Third Quarter 2026 Financial Results on November 6, 2026 GlobeNewswire
TMCITreace Medical Concepts, Inc. Press release Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PRNewsWire
TMCITreace Medical Concepts, Inc. Press release Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure GlobeNewswire
TMCITreace Medical Concepts, Inc. Press release Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting GlobeNewswire
TMCITreace Medical Concepts, Inc. Stock news Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript Seeking Alpha
TMCITreace Medical Concepts, Inc. Stock news Treace Medical Concepts Q2 Earnings Call Highlights MarketBeat
TMCITreace Medical Concepts, Inc. Stock news Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates Zacks Investment Research
TMCITreace Medical Concepts, Inc. Press release Treace Medical Concepts Reports Second Quarter 2026 Financial Results GlobeNewswire
TMCITreace Medical Concepts, Inc. Press release Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PRNewsWire
TMCITreace Medical Concepts, Inc. Press release Treace to Report Second Quarter 2026 Financial Results on August 7, 2026 GlobeNewswire
TMCITreace Medical Concepts, Inc. Legal Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI) GlobeNewswire
TMCITreace Medical Concepts, Inc. Legal Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses GlobeNewswire
TMCITreace Medical Concepts, Inc. Stock news Treace Medical Concepts Q1 Earnings Call Highlights MarketBeat
TMCITreace Medical Concepts, Inc. Stock news Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript Seeking Alpha
TMCITreace Medical Concepts, Inc. Stock news Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates Zacks Investment Research
FAQ

Questions about Treace Medical Concepts, Inc.

What does Treace Medical Concepts, Inc. do?
Treace Medical Concepts, Inc., an orthopedic medical device company, designs, manufactures, and markets medical devices for foot and ankle surgeons in the United States. It offers the Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with cosmetic and medical improvement. The company also provides the Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, Weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
What is TMCI's market cap?
Treace Medical Concepts, Inc. (TMCI) is a listed stock with a live quote. The latest market cap on this page is $284M.
Where is Treace Medical Concepts, Inc. headquartered?
Treace Medical Concepts, Inc. is headquartered in Ponte Vedra, FL.
How do I get TMCI news from the API?
Call GET /v1/news?tickers=TMCI. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does TMCI news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for TMCI, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the TMCI price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.